What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Cancer research, Genetics, Pathology, DNA methylation and Epigenetics.
His Cancer research study combines topics from a wide range of disciplines, such as Cell growth, Oncogene, Gene duplication, Gene and Tissue microarray.
Juan C. Cigudosa is studying Chromosomal translocation, which is a component of Genetics.
Juan C. Cigudosa has included themes like Oncology, Complex Karyotype, Breakpoint, Internal medicine and Trisomy 8 in his Pathology study.
His DNA methylation study combines topics from a wide range of disciplines, such as Carcinogenesis, Virus, Hepatitis B virus and Human virome.
His Epigenetics research integrates issues from Histone, X-inactivation, Genotype and CpG site.
His most cited work include:
- Epigenetic differences arise during the lifetime of monozygotic twins (2717 citations)
- Spontaneous human adult stem cell transformation (930 citations)
- Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression (446 citations)
What are the main themes of his work throughout his whole career to date?
Juan C. Cigudosa mainly focuses on Cancer research, Genetics, Molecular biology, Pathology and Chromosomal translocation.
His biological study spans a wide range of topics, including Cancer, DNA methylation, Gene expression profiling, Mutation and Immunology.
His study in Comparative genomic hybridization, Gene, Karyotype, Chromosome and Leukemia is done as part of Genetics.
His study in Molecular biology is interdisciplinary in nature, drawing from both Gene rearrangement, Cytogenetics, Gene duplication, Fluorescence in situ hybridization and Chromosome instability.
His work carried out in the field of Pathology brings together such families of science as Internal medicine and In situ hybridization.
His work on Breakpoint as part of general Chromosomal translocation research is frequently linked to Acute lymphocytic leukemia, thereby connecting diverse disciplines of science.
He most often published in these fields:
- Cancer research (35.20%)
- Genetics (30.17%)
- Molecular biology (23.46%)
What were the highlights of his more recent work (between 2010-2020)?
- Cancer research (35.20%)
- Genetics (30.17%)
- Gene (15.64%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cancer research, Genetics, Gene, Molecular biology and Mutation.
Juan C. Cigudosa interconnects Cancer, Immunology, DNA methylation and Gene expression profiling in the investigation of issues within Cancer research.
His Immunology research is multidisciplinary, incorporating elements of Apoptosis, Internal medicine and Oncology.
The various areas that he examines in his DNA methylation study include Myeloproliferative Disorders, Epigenetics, Myelodysplastic syndromes and De novo Myelodysplastic Syndrome.
His work deals with themes such as Chromatin, Histone and Erythroid cell, which intersect with Molecular biology.
His work in Myeloid leukemia addresses subjects such as Leukemia, which are connected to disciplines such as Myeloid, Pathology and Dasatinib.
Between 2010 and 2020, his most popular works were:
- Cytogenetic risk stratification in chronic myelomonocytic leukemia (186 citations)
- Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy. (180 citations)
- Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system (167 citations)
In his most recent research, the most cited papers focused on:
Juan C. Cigudosa mostly deals with Genetics, Cancer research, Gene, DNA methylation and Regulation of gene expression.
His Cancer research study incorporates themes from Mutation, Cancer, Real-time polymerase chain reaction and DNA repair.
His research investigates the connection between Gene and topics such as Immunology that intersect with problems in Karyotype and Multivariate analysis.
His DNA methylation research is multidisciplinary, relying on both Methylation, Apoptosis, Essential thrombocythemia, Gene silencing and Epigenetics.
His Epigenetics research incorporates themes from Myeloproliferative Disorders, Differentially methylated regions, Myeloid leukemia, Chronic myelomonocytic leukemia and Myelofibrosis.
His Regulation of gene expression study integrates concerns from other disciplines, such as Gene knockdown, Epigenetic Profile, 5-Methylcytosine and Histone, EZH2.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
